MilliporeSigma
NEWS
Large pharmaceutical companies are making plans to comply with sustainability and carbon net zero targets. Hear from AstraZeneca and Merck KGaA’s MilliporeSigma about their strategies.
In 1996, Udit Batra received his Ph.D. in chemical engineering from Princeton University. 24 years later, he heads a MilliporeSigma, $7.5 billion global life sciences company with a catalog of some 300,000 items used by life sciences researchers and developers throughout the world.
MilliporeSigma announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT resin, a first-to-market product used in biopharmaceutical manufacturing.
MilliporeSigma developed a new filtration-based manufacturing process resulting in a new, highly purified sucrose grade with reduced levels of nanoparticle impurities
MilliporeSigma has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications.
MilliporeSigma introduced its ADC Express TM services for the rapid production of ADCs, which can reduce the time needed to produce development grade constructs for target molecule identification.
MilliporeSigma will launch its ADC Express™ services, which provide rapid production of ADCs for best candidate selection.
MilliporeSigma has acquired all ownership rights to the ProcessPad™ platform from Simplyfeye Softwares Private Limited. The agreement includes the transfer of all copyrights and relevant intellectual property related to this software platform.
New bio-derived product is a safer, more sustainable alternative for Dimethylformamide and N-Methyl-2-pyrrolidone solvents
JOBS
IN THE PRESS